分析
医薬品市場、サプライチェーン、技術、規制の詳細分析
分析2026年9月28日•39分で読めます
Building ERP for Pharmaceutical Manufacturing: Challenges, GxP Requirements, System Architecture and Implementation Strategy
From master data and batch lifecycle to validation, change control and system-of-record ownership: why pharmaceutical ERP is harder than generic ERP, where implementations fail, and how a GxP-ready operating model becomes the foundation automation and AI actually need.
14
1
分析2026年9月22日•40分で読めます
医薬品サプライチェーン全体における自動化とAI:エンドツーエンドのマップ
市場・ポートフォリオの意思決定から薬局、ファーマコビジランスまで——ルールベースの自動化がすでに担っていること、AIが価値を加える領域、そして責任を負う人に委ねるべき意思決定を整理します。
211
2
分析
2026年9月28日•1分で読めます
Pharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
South Korean pharmaceutical distributors announce order cut‑off dates of Sep 21‑23 before the Chuseok holiday, with shipments resuming on Sep 28.
4
分析
2026年9月28日•1分で読めます
South Korea Summer OTC Market Shows Diverging Trends; Acne Treatment Azelia Enters Top 10
Summer pharmacy OTC sales in South Korea displayed mixed movements, with acne drug Azelia rising sharply into the top‑10, while vitamin brands showed varied growth.
2
分析
2026年9月28日•1分で読めます
GSK’s Duac Gel 5% Faces Ongoing Stock Shortage, Resupply Date Unclear
GSK reports its acne treatment Duac Gel 5% remains out of stock with no confirmed resupply timeline, urging pharmacies to monitor inventory.
1
分析
2026年9月27日•1分で読めます
Mounjaro Leads Surge in Korean Obesity Drug Market, Wegovy Falls to 5th
Mounjaro drove over 30% growth in Korea's obesity treatment market in two months, while Wegovy sales fell for two consecutive months, dropping to fifth place.
分析
2026年9月24日•1分で読めます
Oseltamivir Suspension Powder Faces Supply Shortage Amid Rapid Flu Spread in Korea
Pharmacies report stockouts of pediatric oseltamivir suspension powder as influenza cases surge; some manufacturers still hold inventory, but supply pressure is rising.
分析
2026年9月24日•1分で読めます
Galderma Korea Unveils "Injectable Renaissance" Strategy at GAIN RESTAGE Event
Galderma Korea presented a new aesthetic portfolio—including fillers, biostimulators and skincare—at the GAIN RESTAGE event in Seoul, targeting natural, personalized results.
分析
2026年9月23日•1分で読めます
BaroPharm Expands Pharmacy Beauty Zones to 200 Locations, Aims for 1,000 by Year-End
BaroPharm's Pharmacy Beauty Zone reaches 200 outlets within a month, targeting 1,000 pharmacies nationwide by year‑end.
分析
2026年9月23日•1分で読めます
Musinsa Beauty teams with Onnuri Pharmacy for first offline store in Seoul
Musinsa Beauty and the Onnuri pharmacy chain opened their first joint offline store in Hongdae, merging K‑beauty products with pharmacy‑grade cosmetics and skin‑care medicines.
1
分析
2026年9月23日•1分で読めます
Samsung Biologics Secures ~KRW 3.5tn CMO Deal with European Pharma
Samsung Biologics announced a new CMO contract worth about KRW 3.5 trillion (~US$262 million) with a European pharmaceutical company, running until Dec 31 2033.
分析
2026年9月22日•1分で読めます
Jongkundang's Zitec GI drug pushes for reimbursement as insurer weighs clinical and industrial value
Jongkundang is working to secure reimbursement for its domestically developed GI medication Zitec, with the National Health Insurance Service evaluating its clinical usefulness, industrial value, alternative drug pricing, and fiscal impact.